Humanwell Healthcare (Group) Co Ltd (600079)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Humanwell Healthcare (Group) Co Ltd (600079) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010906
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Humanwell Healthcare (Group) Co Ltd (Humanwell), formerly Wuhan Humanwell Hi-Tech Industry Co Ltd is a pharmaceutical company that offers generic products. The company offers pharmaceutical, medical instrument and reproductive health care products and technologies. It provides anesthetics, biological products, herbal medicines, CNS medicines, women’s health, anti-infection drugs, medical devices, OTC medicines and other products. Humanwell also manufactures buflomedil hydrochloride injectable, pantoprazole sodium injectable, omeprazole sodium injectable, phloroglucinol injectable, and simvastatin capsules. The company produces products in the forms of injection, tablets, syrup, granules, capsules, and suspension. Humanwell is headquartered in Wuhan, China.

Humanwell Healthcare (Group) Co Ltd (600079) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Humanwell Healthcare (Group) Co Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Humanwell Healthcare (Group) Co Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Humanwell Healthcare (Group) Co Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Humanwell Healthcare (Group) Co Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Humanwell Healthcare (Group) Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Humanwell Healthcare (Group) Co Ltd, Medical Equipment, Deal Details 10
Private Equity 10
AGIC Capital Acquires Ritedose From Olympus Partners 10
Humanwell Healthcare and CITIC Capital China Partners Acquires Sexual Wellness Business from Ansell for USD600 Million 12
Equity Offering 14
Humanwell Healthcare Decreases Size of Private Placement of Shares for USD174 Million 14
Debt Offering 15
Humanwell Healthcare to Raise USD302 Million in Private Placement of Notes 15
Humanwell Healthcare Raises USD150.8 Million in First Tranche of 4.99% Public Offering of Notes Due 2018 16
Humanwell Healthcare to Raise USD296.81 Million in Commercial Paper Offering 17
Humanwell Healthcare Plans to Raise USD309 Million in Public Offering of Notes 18
Acquisition 19
Wuhan Humanwell Hi-tech Industry To Acquire 80% Stake In Beijing Baron Medical Equipment For US$123 Million 19
Humanwell Healthcare (Group) Co Ltd – Key Competitors 20
Humanwell Healthcare (Group) Co Ltd – Key Employees 21
Humanwell Healthcare (Group) Co Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Humanwell Healthcare (Group) Co Ltd, Medical Equipment, Key Facts, 2016 2
Humanwell Healthcare (Group) Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Humanwell Healthcare (Group) Co Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Humanwell Healthcare (Group) Co Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Humanwell Healthcare (Group) Co Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Humanwell Healthcare (Group) Co Ltd, Deals By Market, 2011 to YTD 2017 8
Humanwell Healthcare (Group) Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
AGIC Capital Acquires Ritedose From Olympus Partners 10
Humanwell Healthcare and CITIC Capital China Partners Acquires Sexual Wellness Business from Ansell for USD600 Million 12
Humanwell Healthcare Decreases Size of Private Placement of Shares for USD174 Million 14
Humanwell Healthcare to Raise USD302 Million in Private Placement of Notes 15
Humanwell Healthcare Raises USD150.8 Million in First Tranche of 4.99% Public Offering of Notes Due 2018 16
Humanwell Healthcare to Raise USD296.81 Million in Commercial Paper Offering 17
Humanwell Healthcare Plans to Raise USD309 Million in Public Offering of Notes 18
Wuhan Humanwell Hi-tech Industry To Acquire 80% Stake In Beijing Baron Medical Equipment For US$123 Million 19
Humanwell Healthcare (Group) Co Ltd, Key Competitors 20
Humanwell Healthcare (Group) Co Ltd, Key Employees 21
Humanwell Healthcare (Group) Co Ltd, Subsidiaries 22

★海外企業調査レポート[Humanwell Healthcare (Group) Co Ltd (600079)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Maintel Holdings Plc (MAI):企業の財務・戦略的SWOT分析
    Summary Maintel Holdings Plc (Maintel) is a telecommunication service provider that supports voice and data equipments. The company provides collaborations, customer experience and optimization, connectivity, security and networking, mobile professional and transformation services and managed servic …
  • Charter Communications Inc (CHTR):企業の財務・戦略的SWOT分析
    Charter Communications Inc (CHTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Union Bank of India:企業のM&A・事業提携・投資動向
    Union Bank of India - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Union Bank of India Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Range Resources Corporation:企業の戦略・SWOT・財務情報
    Range Resources Corporation - Strategy, SWOT and Corporate Finance Report Summary Range Resources Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • CUB Pty Ltd:企業の戦略的SWOT分析
    CUB Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Newfield Exploration Company:企業のM&A・事業提携・投資動向
    Newfield Exploration Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Newfield Exploration Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Zimplats Holdings Ltd:企業の戦略・SWOT・財務情報
    Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • GW Pharmaceuticals Plc (GWP):医療機器:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Unit Corp (UNT):企業の財務・戦略的SWOT分析
    Summary Unit Corp (Unit) is a diversified energy company that offers exploration and production of oil and natural gas. The company offers acquisition of producing oil and natural gas properties, contract drilling of onshore oil and natural gas wells, and gathering and processing of natural gas. It …
  • Zagro Asia Ltd:企業の戦略的SWOT分析
    Zagro Asia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Sul America SA:企業の戦略・SWOT・財務情報
    Sul America SA - Strategy, SWOT and Corporate Finance Report Summary Sul America SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Compuware Corp:企業の戦略・SWOT・財務分析
    Compuware Corp - Strategy, SWOT and Corporate Finance Report Summary Compuware Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Elisa Oyj (ELISA):企業の財務・戦略的SWOT分析
    Elisa Oyj (ELISA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Russian Reinsurance Company:企業の戦略・SWOT・財務分析
    Russian Reinsurance Company - Strategy, SWOT and Corporate Finance Report Summary Russian Reinsurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • BE Semiconductor Industries N.V. (BESI):企業の財務・戦略的SWOT分析
    BE Semiconductor Industries N.V. (BESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Dicerna Pharmaceuticals Inc (DRNA):企業の財務・戦略的SWOT分析
    Summary Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of rare inherited diseases and cancers. The company’s lead product DCR-PHXC is used for the treatment of primary hyperoxaluria (PH). It offers RNAi technology platf …
  • Richardson Electronics Ltd (RELL):企業の財務・戦略的SWOT分析
    Summary Richardson Electronics Ltd (Richardson Electronics) manufactures electron tube. It offers engineered solutions, power grid and microwave tubes and consumables, displays, flat panel detector solutions and parts for diagnostic imaging equipment, power conversion and RF and microwave components …
  • National Bank of Canada:企業の戦略・SWOT・財務分析
    National Bank of Canada - Strategy, SWOT and Corporate Finance Report Summary National Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bank Otkritie Financial Corp:企業の戦略・SWOT・財務分析
    Bank Otkritie Financial Corp - Strategy, SWOT and Corporate Finance Report Summary Bank Otkritie Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Kulim (Malaysia) Bhd:企業の戦略的SWOT分析
    Kulim (Malaysia) Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆